Extended Release PLGA Nanoparticles for Chronic Pain

Creative Commons License

Öztürk A. A., Martin Banderas L., Cayero Otero M. D., Yenilmez E., Yazan E. Y.

12. İnternation Symposium on Pharmaceutical Sciences (ISOPS 12), Ankara, Turkey, 26 - 29 June 2018, pp.281

  • Publication Type: Conference Paper / Full Text
  • City: Ankara
  • Country: Turkey
  • Page Numbers: pp.281
  • Anadolu University Affiliated: Yes

Abstract

The pain situation has a very important effect on the biological, psychological, sociological and economic situation of the patient (1). Dexketoprofen trometamol (DT) has been developed as a water-soluble trometamine salt. DT is a rapidly acting analgesic agent in the treatment of painful musculoskeletal disorders such as back pain and osteoarthritis (2). In this study; DT loaded PLGA Nanoparticles (NPs) formulated with Double emulsions Solvent evaporation method which is the most suitable method for preparing PLGA NPs for hydrophilic drugs.